Title of article :
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
10
From page :
1096
To page :
1105
Abstract :
Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drugʹs ability to prevent type 2 diabetes in individuals at high risk of developing
Journal title :
The Lancet
Serial Year :
2007
Journal title :
The Lancet
Record number :
590276
Link To Document :
بازگشت